Colchicine is beneficial in the treatment of cirrhotic patients, it prevents changes in plasma membrane bound enzymes induced by CC14 intoxication. In this study, lipid composition and microviscosity were measured in liver plasma membranes isolated from rats given CC14. Microviscosity values increased in rats given CC14 for six weeks but fell considerably in those given CC14 for 10 weeks. Both these changes were absent when colchicine was given with CCI4. The The mechanism of this protective effect is not clear. Colchicine has an extremely wide range of biological actions. It inhibits collagen production,4 stimulates collagenase activity,5 and blocks mitos0S6 and some functions of polymorphonuclear leucocytes,7 some of which are related to its antimicrotubular effect.8 In addition, changes in plasma membrane bound enzymes were prevented and the high cholesterol/phospholipid molar ratio was reversed, when colchicine was given simultaneously with CC14 in rats that already had cirrhosis after eight weeks of CC14 treatment.9 It is well known that a number of membrane bound enzymes may be affected by the lipid environment of the hepatocyte plasma membrane. " ' This membrane consists of a lipid bilayer into which a variety of proteins (structurals, enzymes, receptors, transporters) are inserted." It has been shown that the structural order in membrane, determined by its lipid and protein content, can influence a variety of functions and physicochemical properties of plasma membrane, including enzyme activity, transport, fluidity, and microviscosity."I Microviscosity ( ) of anisotropic bilayer membranes is related to motional resistance and increases parallel to the packing of lipids. In contrast, fluidity, applies to the relative motional freedom of the lipid molecules into the bilayer membrane'3 and its increase expresses a decreased structural order.
Preliminary trials of colchicine in animals and patients with liver cirrhosis showed that this drug produces an improvement in liver function, reduces the fibrous content of the liver' and may be beneficial in this disease.2 More recently, Kershenobich et al3 reported the results of a longterm, controlled study and confirmed that colchicine prolongs survival in patients with mild to moderate cirrhosis of the liver and improves liver histology in some cirrhotic patients.
The mechanism of this protective effect is not clear. Colchicine has an extremely wide range of biological actions. It inhibits collagen production,4 stimulates collagenase activity,5 and blocks mitos0S6 and some functions of polymorphonuclear leucocytes,7 some of which are related to its antimicrotubular effect. 8 In addition, changes in plasma membrane bound enzymes were prevented and the high cholesterol/phospholipid molar ratio was reversed, when colchicine was given simultaneously with CC14 in rats that already had cirrhosis after eight weeks of CC14 treatment.9 It is well known that a number of membrane bound enzymes may be affected by the lipid environment of the hepatocyte plasma membrane. " ' This membrane consists of a lipid bilayer into which a variety of proteins (structurals, enzymes, receptors, transporters) are inserted." It has been shown that the structural order in membrane, determined by its lipid and protein content, can influence a variety of functions and physicochemical properties of plasma membrane, including enzyme activity, transport, fluidity, and microviscosity."I Microviscosity ( ) of anisotropic bilayer membranes is related to motional resistance and increases parallel to the packing of lipids. In contrast, fluidity, applies to the relative motional freedom of the lipid molecules into the bilayer membrane'3 and its increase expresses a decreased structural order.
The purpose of the present study was: (1) to investigate the effect of CC14 on the physicochemical properties and lipid composition of liver plasma membrane and (2) to evaluate the preventive effect of colchicine on the changes induced in these membranes by longterm administration of CC14 in rats.
Methods
Male Wistar rats weighing 200 to 250 g had free access to a diet of Purina chow and water. Animals were divided into six groups. Group I (five rats) received 150 uld/100 g body weight of corn oil by intraperitoneal injection, three times a week for six weeks. Group II comprised seven rats that received 10 [tg/day of colchicine for five days a week. Colchicine was dissolved in water and given by intragastric tube. In group III (five rats), 150 ,ud/100 g body weight of a 1:7 (v/v) solution of CC14 in corn oil was given by intraperitoneal injection three times a week for six weeks. In animals of group IV (six rats), CC14 administration was maintained for 10 weeks. Animals of group V (eight rats) and VI (seven rats) were given 10 kg/day of colchicine for five days a week, in addition to CC14 as described for animals in the groups III and IV, respectively. This study was approved by the hospital research committee and the standard criteria for the care and use of laboratory animals in research were followed.
PREPARATION OF LIVER PLASMA MEMBRANES
Rat liver plasma membranes were isolated and purified according to the method of Neville,'4 as modified by Emmelot. 'S The purity of the membrane suspensions and the degree of contamination with intracellular organelles were assessed by phase-contrast microscopy and by marker enzymes. The 5'-nucleotidase activity'6 was used as a plasma membrane marker and glucose 6-phosphatase and cytochrome c oxidase were (Fig 1, Table II ).
LIPID COMPOSITION OF LIVER PLASMA MEMBRANE
The cholesterol -content in liver plasma membranes increased and the phospholipid content fell after longterm administration of CC14. However, none of these changes reached statistical significance. In spite of this, cholesterol/ phospholipid molar ratios increased significantly in these animals, particularly in those exposed to CC14 for 10 weeks. This ratio was normal in rats given colchicine in addition tO CC14 (Table II) . Although lipid peroxides (measured as TBARS) increased steadily during CC14 intoxication, the addition of colchicine completely prevented peroxidation of lipids in plasma membranes (Fig 2) . The fatty acid patterns of the phospholipids showed that the length and the unsaturation index of fatty acyl chains decreased after six weeks and was particularly noticeable after 10 weeks of intoxication with CC14, but these changes were also abolished by the colchicine treatment (Figs 3  and 4) .
Lipid peroxidation was significantly and inversely correlated with the index of unsaturation (r= -0-94), length of fatty acyl chains (r=-0 86), and content of phospholipids (r=-0 9) in the liver plasma membranes. In addition, lipid peroxidation was positively correlated with the cholesterol/phospholipid molar ratio in these membranes (r=0 80). There was no significant correlation between microviscosity and the lipid composition of liver plasma membranes.
Discussion
Colchicine was shown to be beneficial in the treatment of patients with mild to moderate cirrhosis of the liver3 and pretreatment of rats with this drug prevented liver damage induced by D-galactosamine2t or CC14.29 The mechanism of these effects is not clear. CC14 toxicity occurs after cleavage of a carbon-chlorine bond and the generation of trichloromethyl free radicals. These high reactive metabolites initiate peroxidative damage of membrane phospholipids, including plasma cell membrane. Breakdown of these membranes changes their physicochemical properties, and may result in hepatocellular necrosis.
Our study shows that chronic administration of CC14 for six weeks induces an increase in liver plasma membrane microviscosity. However, maintaining this treatment for 10 weeks leads to the opposite effect (Fig 1) . All these physical changes were prevented by simultaneous administration of colchicine. Studies on the effects ofCC14 on cell membranes are scanty, but indicate that acute CC14 poisoning results in a significant increase in microsomal membrane fluidity.3233 It is well known that membrane lipid composition is an important factor in determining membrane physicochemical properties.'0 34CC14 intoxication was associated with a rise in the cholesterol/phospholipid molar ratio and an appreciable increase in lipid peroxidation. In contrast, the phospholipid content decreased after CC14 (Table II) . The mechanism ofaction of the latter effect is unclear, however, as the phospholipid value was inversely correlated with lipid peroxides in plasma membranes. Otani et al,30 using a model of lipid peroxidation induced by ischaemia-reperfusion, also reported a significant depletion of membrane phospholipids that was associated with an inhibition of membrane phospholipid synthesis. Some enzymes involved in the regulation of phospholipid biosynthesis are located in the endoplasmic reticulum. 35 It is considered that the initial event of liver injury induced by CC14 takes place in these membranes, where this agent causes a highly focal lipid peroxidation. We speculate that the CC14 induced damage of microsomal membrane is followed by inhibition of phospholipid biosynthesis. Lipid peroxidation induced by CC14 may also promote the degradation of phospholipids and may play a part in the reduction of phospholipids in the plasma membranes, since damaged fatty acids are cleaved, presumably as a repair process.36 Our results agree with this mechanism -the length and degree of unsaturation of fatty acyl chains decreased appreciably in rats given CC14, and these changes were closely and negatively correlated with lipid peroxide content in plasma membrane. Lipoperoxidative degradation of fatty acyl chains might have been followed by the exclusion of the hydrophilic head of phospholipids from the biomembrane. The appreciable increase in membrane microviscosity induced by chronic intoxication with CC14 for six weeks could be ascribed to the rise in the cholesterol/phospholipid molar ratio."'0 The decrease in microviscosity after 10 weeks of poisoning could be attributed to the peroxidative shortening of the unsaturated fatty acyl chains. These shorter acyl chains decrease chain-chain interactions, reduce microviscosity,'0 and could overcome the effect of the increased cholesterol/ phospholipid molar ratio on microviscosity.
With regard to the central part played by the lipid peroxidation in the CC14 induced liver injury, the protective effect of colchicine against liver plasma membrane changes in CC14 treated rats could be ascribed to its capacity to inhibit peroxidation offatty acids (Fig 2) . Similar effects of colchicine have been previously reported in D-galactosamine induced hepatitis28 and in acute liver damage induced by CC14.29 Although the mechanism of this apparently antilipoperoxidant effect is not known, it has been suggested that colchicine may act as a free radical scavenger.37 Other actions at the activation step of CC14 by microsomal enzymes or at the level of the propagation of lipid peroxidation cannot, however, be ruled out. 29 Many of the biological actions of colchicine are related to its antimicrotubular effect.8 38 A number of reports have emphasised the relation between microtubules and phospholipids of plasma membranes39 and have shown that lipid-protein interactions within plasma membrane may also modify microviscosity.'" Therefore, the protective effect of colchicine against changes in liver plasma membrane could be attributed to its antitubular properties. Exposure of isolated cells to colchicine (5 to 6-3 FtM) results in changes in the physicochemical properties of plasma membranes4' 42 that can be blocked by some microtubule stabilising agents.4' Although we cannot exclude this mechanism, it seems to be unlikely at the doses used in our study. Rats given longterm colchicine treatment showed no significant changes in the physicochemical characteristics of plasma membranes (Fig 1) and these results concur with those reported by Shiba et al43 which showed that colchicine did not affect membrane fluidity. Furthermore, the antimicrotubular effects of colchicine are noted with much higher doses than those used in the present study. Cerbon et al44 showed that the colchicine concentration in rat liver 12 hours after a subcutaneous injection of 10 [ig colchicine was less than 5 ng/g of tissue.
In conclusion, longterm administration of CC14 to rats resulted in a variety of changes in the physicochemical characteristics of liver plasma membrane, including increased fluidity, lipid peroxidation, and shortening of the fatty acyl chains of phospholipids. All these events were prevented, however, when rats were simultaneously treated with colchicine. This agent may act by hampering lipoperoxidation of fatty acyl chains. 
